Unlocking
the future
of medicine

About us
 
 
 

An immunotherapy platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ immunotherapy has the potential to treat many disease areas, including cancer.

Highlights

Nykode Therapeutics reports Q1 2025 Financial Results

Read More
28 May 2025

Nykode Therapeutics – invitation to Q1 2025 financial results ...

Read More
26 May 2025

Nykode Therapeutics Highlights New Data in Two Poster Presentations ...

Read More
23 May 2025